Objective To investigate the concentration of miRNA-182 in esophageal carcinoma and its association with disease prognosis. Methods MicroRNA-182 in 59 esophageal carcinoma tissues and related adjacent healthy tissues were measured by quantitative real time polymerase chain reaction (qRT -PCT). Association of miRNA -182 with clinical characters including pathologic types, and clinical outcome was determined. Results The concentration of miRNA -182 in esophageal carcinoma tissues was significantly increased when compared with that in adjacent healthy tissues (P < 0.05). Overexpression of miRNA-182 correlated closely with tumor differentiation level, depth of infiltration, metastasis, and clinical stage (P < 0.05). Kaplan -Meier survival analysis indicated that patients with high miRNA -182 experienced worse outcome compared with others (P < 0.05). Moreover, multivariate analysis showed that increase of miRNA-182 was an independent predictor of overall survival (P < 0.05). Conclusions MicroRNA-182 is overexpressed in esophageal carcinoma tissue and concentration of miRNA-182 is closely correlated with poor outcome, suggesting that miRNA-182 may serve as a prognostic biomarker for esophageal carcinoma.